TA180: Psoriasis - ustekinumab
This is a discussion on TA180: Psoriasis - ustekinumab within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Psoriasis - ustekinumab . It links to the published guidance and key documents. More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 11:51 AM
|
|||
|
|||
TA180: Psoriasis - ustekinumab
The summary for the published technology appraisal on Psoriasis - ustekinumab . It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA134: Psoriasis - infliximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 11:51 AM |
| TA146: Psoriasis - adalimumab | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 11:51 AM |
| TA180: Psoriasis - ustekinumab | industry_news | Updates from the Technology Assessment Authorities | 0 | 09-22-2009 07:06 PM |
| Ustekinumab pipeline update August 2008 | diana.papshev | Specialty Drug Pipeline by Month | 0 | 08-10-2008 05:44 PM |
| Ustekinumab pipeline update June 2008 | chantell.reagan | Specialty Drug Pipeline by Month | 0 | 06-13-2008 02:44 PM |
© 2008 DrugManagementForum™ powered by |
 |